SCHEMBL25811868

SCHEMBL25811868

O=C(OCc1ccccc1)c1c(F)c(-c2ccc(Cl)cc2)c(F)c(C(=O)OCc2ccccc2)c1C(=O)OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 1/20 0.48
ALDH1A1 P00352 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ALOX5 P09917 1/20 0.47
DHODH Q02127 2/20 0.46
KMT2A Q03164 3/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MMP2 P08253 2/20 0.45
MMP1 P03956 1/20 0.45
MMP9 P14780 1/20 0.45
MMP12 P39900 1/20 0.45
GPBAR1 Q8TDU6 3/20 0.45
MEN1 O00255 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4507007 0.76 CA1 (0.62) ALDH1A1CYP3A4L3MBTL1KMT2ASLC6A2
SCHEMBL9754469 0.75 TDP1 (0.51) GCGRALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL2705832 0.75 KMT2A (0.76) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL21993312 0.74 CA1 (0.60) ALDH1A1KMT2ASLC6A2SLC6A3TDP1
SCHEMBL21470255 0.74 ALOX5 (0.53) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10611772 0.73 KMT2A (0.73) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL26075682 0.72 ALDH1A1 (0.50) ALDH1A1CYP3A4NPSR1L3MBTL1KMT2A
SCHEMBL24874101 0.71 TDP1 (0.51) ALDH1A1KMT2ASLC6A2SLC6A3TDP1
SCHEMBL20083707 0.71 TDP1 (0.59) ALDH1A1CYP3A4L3MBTL1KMT2ASLC6A2
SCHEMBL2357688 0.71 KMT2A (0.76) ALDH1A1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230189636-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF EMC1, EMC2, EPCAM GCGR 4701/4885ALDH1A1 969/4885CYP1A2 1633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.